1. Home
  2. CUE vs CMTL Comparison

CUE vs CMTL Comparison

Compare CUE & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

N/A

Current Price

$0.31

Market Cap

27.1M

Sector

Health Care

ML Signal

N/A

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

N/A

Current Price

$5.07

Market Cap

162.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CUE
CMTL
Founded
2014
1967
Country
United States
United States
Employees
N/A
1385
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
27.1M
162.1M
IPO Year
2017
2024

Fundamental Metrics

Financial Performance
Metric
CUE
CMTL
Price
$0.31
$5.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.00
$6.00
AVG Volume (30 Days)
343.6K
218.3K
Earning Date
01-01-0001
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
35.14
N/A
EPS
N/A
N/A
Revenue
$9,287,000.00
$499,528,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$25.00
$1.97
P/E Ratio
N/A
N/A
Revenue Growth
69.16
N/A
52 Week Low
$0.23
$1.19
52 Week High
$1.12
$6.21

Technical Indicators

Market Signals
Indicator
CUE
CMTL
Relative Strength Index (RSI) 51.95 44.45
Support Level $0.26 $4.86
Resistance Level $0.36 $6.15
Average True Range (ATR) 0.02 0.33
MACD 0.01 -0.04
Stochastic Oscillator 65.48 25.56

Price Performance

Historical Comparison
CUE
CMTL

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.

Share on Social Networks: